CytomX Therapeutics (CTMX) Stock: Buy, Sell, or Hold?
CTMX - CytomX Therapeutics, Inc.
$3.29
-0.06 (-1.79%)
▼
5d:
-10.6%
30d:
-5.73%
90d:
+10.4%
WAIT
LOW Confidence
Analysis Updated: Sep 11, 2026 12:00 AM ET
Earnings: Nov 05, 2026
Smart Money Distribution
Options positioning is turning defensive after a sharp run-up - a pattern consistent with institutional profit-taking. View Scanner →
Signal fired Sep 4, 2026 at $3.71 · last confirmed Sep 9, 2026
Strength: 6.4/10
Get Alerted When CTMX Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
⏸️ WAIT FOR STABILIZATION: CTMX is down 10.6% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
⏸️ WAIT FOR STABILIZATION: CTMX is down 10.6% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
In-depth Analysis How we analyze
Valuation Analysis: CTMX is currently trading at $3.29, which is considered slightly low relative to its 30-day fair value range of $3.28 to $3.57.
Technical Outlook: Technically, CTMX is in a downtrend. Immediate support is located at $3.17, while resistance sits at $3.88.
Market Sentiment: The stock scores a mixed 47/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Wall Street analysts see significant upside, with an average price target of $12.25 (+272.3%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, CTMX is in a downtrend. Immediate support is located at $3.17, while resistance sits at $3.88.
Market Sentiment: The stock scores a mixed 47/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Wall Street analysts see significant upside, with an average price target of $12.25 (+272.3%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
SLIGHTLY LOW
Historical Trading Range
$3.28 -
$3.57
Company Quality Score
48/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
82.6%
All Signals
- BULLISH: Price oversold vs 30-day range
- NEUTRAL: Mixed technical signals (47/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 272.3% below Wall St target ($12.25)
- WARNING: Composite score 48/100 in the bottom quintile — this cohort historically lags the market
Trading Range Analysis
30-Day Trading Range
$3.28 -
$3.57
Current vs Trading Range
SLIGHTLY LOW
Support & Resistance Levels
Support Level
$3.17
Resistance Level
$3.89
Current Trend
Downtrend
Technical data as of
Sep 11, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-6.95
Wall Street Target
$12.25
(+272.3%)
Revenue Growth (YoY)
-92.4%
Earnings Growth (YoY)
60.6%
Share & Embed Analysis
Last updated: September 12, 2026 8:19 PM ET
Data refreshes hourly during market hours. Next update: 9:19 PM
Data refreshes hourly during market hours. Next update: 9:19 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is CTMX showing a specific setup today?
Insider Activity (6 Months)
0
Buys
4
Sells
Net
INSIDERS SELLING
Recent Transactions
Christopher Ogden
SELL
19323 shares
2026-03-17
Marcia Belvin
SELL
31492 shares
2026-03-17
Sean A Mccarthy
SELL
118969 shares
2026-03-17
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
LEGN
Legend Biotech Corp |
STRONG BUY
22 analysts |
$49 | 44 HOLD |
|
ARGX
argenx NV ADR |
STRONG BUY
22 analysts |
$1180 | 43 HOLD |
|
SRPT
Sarepta Therapeutics Inc |
STRONG BUY
26 analysts |
$22 | 34 SELL |
|
KYMR
Kymera Therapeutics Inc |
STRONG BUY
20 analysts |
$135 | 47 HOLD |
|
MRUS
Merus BV |
STRONG BUY
17 analysts |
$97 | 39 SELL |
